期刊文献+

美金刚对血管性痴呆大鼠海马N-甲基-D-天冬氨酸-2B受体的影响 被引量:6

Effect of memantine on NMDAR-2B in hippocampus of vascular dementia rats
下载PDF
导出
摘要 目的观察经美金刚治疗的血管性痴呆(VaD)大鼠海马N-甲基D-天冬氨酸-2B受体(NMDAR-2B)的变化,并探讨其在VaD中的作用机制。方法采用永久性结扎双侧颈总动脉方法制备VaD大鼠模型,将128只Wistar大鼠随机分为假手术组、VaD模型组和美金刚高、低剂量治疗组,每组32只,各组分别于术后4、8、12、16周处死8只大鼠。用Morris水迷宫衡量大鼠学习记忆水平,用免疫组织化学法检测大鼠海马NMDAR-2B的表达。结果随缺血时间延长,VaD模型组大鼠的学习记忆能力下降,与假手术组比较有显著性差异(P<0.01);NMDAR-2B的表达在缺血4周时明显高于假手术组(P<0.01),此后逐渐减少,并显著低于假手术组(P<0.01),缺血16周时表达最少。学习记忆水平及NMDAR-2B的表达美金刚高、低剂量治疗组在缺血4周时与假手术组比较无显著性差异,在缺血8、12、16周时,美金刚高剂量治疗组较VaD模型组显著好转但仍低于假手术组(P<0.01,P<0.05),美金刚低剂量治疗组与模型组无显著差异但明显低于假手术组(P<0.05,P<0.01)。结论VaD大鼠学习记忆的改变与海马NMDAR-2B变化相关,可用适量的美金刚对NMDAR-2B调节以改善VaD大鼠认知功能。 Objective To investigate the mechanism of action of memantine in vascular dementia by studying the change of N methyl-D aspartate-2B receptor(NMDAR-2B) in hippocampus of vascular dementia rats. Methods 128 Wistar rats were randomly divided into sham operation group, vascular dementia (VaD) model group and memantine groups treated with high or low dose. Eight rats of each group were sacrificed at 4,8,12,16 weeks post operation. The water maze test was performed to examine the ability of learning and memory of the rats and the expression of NMDAR-2B in hippocampus was measured by immunohistochemical staining. Results The ability of learning and memory of VaD rats decreased significantly compared with the sham rats. The ex pression of NMDAR 2B in VaD rats increased greatly first then fell down and was significantly different from that of the sham group. At 4 weeks post operation,both memantine treated groups presented no statistical difference in learning and memory level and the expression of NMDAR-2B compared with the sham group. However,at 8,12,16 weeks post operation,the above two indexes of high dose group were better than those of VaD rats, but still worse than those of the sham group. Conclusion The change of NMDAR-2B was related to the impairment of learning and memory of VaD rats and memantine at adequate dosage improved recognition function by modulating NMDAR-2B.
出处 《中华老年心脑血管病杂志》 CAS 北大核心 2007年第11期771-774,共4页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
关键词 痴呆 血管性 海马 受体 N甲基-D-天冬氨酸 美金刚 记忆 dementia, vascular hippocampus receptors, N methyl-D-aspartate memantine memory
  • 相关文献

参考文献6

  • 1Kumar S. Memantine:Pharmacological properties and clinical uses[J]. Neurol India, 2004,52: 307-309.
  • 2Clayton DA, Mesches MH, Alvarez E, et al. A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat[J]. J Neurosci, 2002,22: 3628-3637.
  • 3袁维秀,杨红菊,张宏.N-甲基-D-天冬氨酸-2B受体功能的研究进展[J].国外医学(药学分册),2004,31(3):146-149. 被引量:12
  • 4Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-D-aspartate(NMDA) receptor antagonist:a review of preclinical date [J]. Neuropharmacology, 1999,38:735-767.
  • 5Sonkusare SK, Kaul CI, Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope[J]. Pharmacol Res, 2005,51 : 1-17.
  • 6Hesselink MB, De Boer AG, Breimer DD, et al. Adaptations of NMDA and dopamine D2, but not of muscarinic receptors following 14 days administration of uncompetitive NMDA receptor antagonists[J]. J Neural Transm, 1999,106: 409-421.

二级参考文献19

  • 1Curras-Collazo MC, Dao J. Osmotic activation of the hypothalamo-neurohypophysial system reversibly downregulates the NMDA receptor subunit, NR2B, in the supraoptic nucleus of the hypothalamnus[ J]. Brain Res Mol Brain Res,1999, 70(2): 187 - 196.
  • 2Clayton DA, Mesches MH, Alvarez E, et al. A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat[J].J Neurosci, 2002, 22(9) :3628 - 3637.
  • 3Dunah AW, Wang Y, Yasuda RP, et al. Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease [ J ]. Mol Pharmacol, 2000, 57(3):342-352.
  • 4Oh S, Kim JI, Chung MW, et al. Modulation of NMDA receptor subunit mRNA in butorphanol-tolerant and-withdrawing rats[J]. Neurochem Res, 2000, 25(12):1603-1611.
  • 5Loftis JM, Janewsky A. The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation,and clinical implications[J]. Pharmacol Ther, 2003,97(1):55-85.
  • 6Li L, Fan M, Icton CD, et al. Role of NR2B-type NMDA receptors in selective neurodegeneration in Huntington disease. Neurobiol Aging, 2003, 24(8):1113- 1121.
  • 7Ali DW, Salter MW. NMDA receptor regulation by Src kinase signaling in excitatory synaptic transmission and plasticity[J]. Curr Opin Neurobiol, 2001, 11(3):336 -342.
  • 8Retter LM, Unis AS, Meador-Woodmff JH. Ontogeny of ionotropic glutamate receptor expression in human fetal brain[J]. Brain Res Dev Brain Res, 2001, 127(2):123 -133.
  • 9Herkert M, Rottger S, Becker CM. The NMDA receptor subunit NR2B of neonatal rat brain: complex formation and enrichment in axonal growth cones [ J ]. Eur J Neurosci,1998, 10(5): 1553 - 1562.
  • 10Charton JP, Herkert M, Becker CM, et al. Cellular and subcellular localization of the 2B-subunit of the NMDA receptor in the adult rat telencephalon[J]. Brain Res, 1999,816(2):609-617.

共引文献11

同被引文献56

引证文献6

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部